+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Healthcare Analytical Testing Services Market - Global Forecast 2026-2032- Product Image
Healthcare Analytical Testing Services Market - Global Forecast 2026-2032- Product Image
Sale

Healthcare Analytical Testing Services Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5470915
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Healthcare Analytical Testing Services Market is projected to reach USD 16.46 Billion in 2026. It is expected to continue growing at a CAGR of 10.56%, reaching USD 30.17 Billion by 2032.

Healthcare analytical testing services have become central to medicine quality, patient safety, clinical research integrity, and regulatory compliance. The field spans bioanalytical testing, microbiology, sterility assurance, endotoxin testing, stability studies, method development and validation, raw material testing, contaminant analysis, extractables and leachables, environmental monitoring, and release testing for pharmaceuticals, biologics, vaccines, medical devices, cell and gene therapies, and combination products. Demand is being shaped by increasingly complex therapeutic modalities, globalized supply chains, stricter quality expectations, and the need for faster yet reliable evidence generation across development, manufacturing, and post-market surveillance. As healthcare systems emphasize precision medicine, biologics, and advanced therapies, analytical testing is shifting from a compliance support function to a strategic enabler of product robustness, regulatory readiness, and lifecycle risk management.

Transformative Shifts in the Healthcare Analytical Testing Landscape

The healthcare analytical testing services landscape is undergoing a structural transformation driven by scientific complexity, regulatory harmonization, and digital quality modernization. Biologics, biosimilars, oligonucleotides, mRNA platforms, viral vectors, and cell-based products require specialized assays, orthogonal characterization, impurity profiling, potency testing, and contamination control strategies beyond conventional small-molecule workflows. Regulators are placing greater emphasis on data integrity, risk-based validation, lifecycle management, and traceability across laboratory processes, consistent with good laboratory practice, good manufacturing practice, and electronic records expectations. At the same time, manufacturers are seeking more agile testing models to reduce development bottlenecks, strengthen batch-release confidence, and support decentralized or multi-site production networks. Automation, laboratory information management systems, electronic records, and advanced analytics are increasingly embedded into quality control and research laboratories, enabling better sample tracking, deviation management, and reproducibility. Sustainability and supply resilience are also influencing laboratory operations through solvent reduction, greener analytical methods, qualified alternative suppliers, and diversified testing networks.

Cumulative Impact of Artificial Intelligence on Analytical Testing

Artificial intelligence is beginning to reshape healthcare analytical testing by improving the speed, consistency, and interpretability of laboratory data while supporting stronger quality risk management. AI-enabled tools are being applied to chromatographic peak integration, spectral interpretation, image-based microbiology, anomaly detection, predictive maintenance of instruments, and trend analysis for environmental monitoring and stability programs. In bioanalytical and pharmacokinetic studies, machine learning can support pattern recognition, assay optimization, and outlier investigation, while natural language processing can accelerate review of protocols, deviations, standard operating procedures, and regulatory documentation. The cumulative impact is not the replacement of validated scientific judgment, but the augmentation of laboratory decision-making through faster signal detection, reduced manual variability, and improved data review efficiency. Adoption remains dependent on validated algorithms, explainability, cybersecurity, data governance, audit trails, and alignment with good laboratory practice, good manufacturing practice, and electronic records requirements. Organizations that embed AI within controlled quality systems are better positioned to improve throughput, consistency, and inspection readiness without compromising compliance.

Key Regional Insights Across Healthcare Analytical Testing

Asia-Pacific is strengthening its role in healthcare analytical testing services as pharmaceutical manufacturing capacity, biosimilar development, vaccine production, and clinical research activity expand across China, India, Japan, South Korea, Australia, and ASEAN economies. Regulatory agencies in the region increasingly emphasize internationally aligned quality standards, creating demand for validated methods, bioanalytical support, sterility testing, stability programs, and contamination control. Europe is characterized by mature regulatory frameworks, established pharmaceutical quality systems, advanced biologics capabilities, and strong adoption of pharmacopoeial and good manufacturing practice standards, making analytical validation, batch-release testing, and biologics characterization essential across the region. North America remains a highly advanced testing environment, supported by strong biopharmaceutical research, complex biologics pipelines, medical device innovation, and rigorous regulatory oversight that prioritizes data integrity, contamination control, validated analytical methods, and lifecycle quality management. Latin America is gaining relevance as regional manufacturing, public health programs, and clinical trial participation require stronger quality testing infrastructure, particularly in Brazil and Mexico. Africa’s development is shaped by expanding medicine access initiatives, infectious disease surveillance, vaccine quality needs, and the gradual strengthening of national regulatory and laboratory systems, with demand concentrated around quality assurance, microbiology, and public health-linked testing. The Middle East is investing in healthcare infrastructure, local manufacturing, and laboratory modernization, creating opportunities for analytical testing in medicines quality, diagnostics support, import verification, and regulatory compliance.

Key Group Insights for Healthcare Analytical Testing Services

NATO member countries, many of which overlap with highly regulated healthcare markets, place additional emphasis on secure supply chains, medical preparedness, and resilient quality systems, supporting demand for dependable analytical testing across essential medicines, vaccines, and medical countermeasure readiness. G7 countries remain central to high-complexity analytical testing due to advanced biopharmaceutical innovation, established regulatory systems, strong inspection cultures, and sustained investment in precision medicine, biologics, and advanced therapies. The European Union provides one of the world’s most harmonized regulatory environments for medicines and medical devices, reinforcing demand for validated analytical methods, batch-release testing, pharmacopoeial compliance, data integrity, and advanced biologics characterization. BRICS economies represent a broad base of pharmaceutical production, generics supply, vaccine capabilities, and expanding healthcare access, creating diverse needs across raw material testing, finished product release, bioanalytical services, and contamination control. ASEAN is increasingly important for healthcare analytical testing services as member economies strengthen pharmaceutical manufacturing, medical tourism, clinical research, and regulatory convergence initiatives, with testing demand focused on quality control, bioequivalence, stability, and microbiology. The GCC is advancing healthcare localization and life sciences investment, making analytical testing essential for medicine registration, import quality verification, emerging regional manufacturing, and healthcare quality assurance.

Key Country Insights Across Major Testing Environments

The United States is a leading environment for healthcare analytical testing services due to its advanced biopharmaceutical pipeline, strong regulatory scrutiny, extensive clinical research activity, and widespread adoption of complex biologics, cell therapies, gene therapies, and medical technologies. China’s large-scale pharmaceutical production, biologics expansion, vaccine capabilities, and regulatory modernization are driving sophisticated testing needs, while Germany emphasizes pharmaceutical quality, precision engineering, advanced laboratory infrastructure, and strong good manufacturing practice compliance. Japan’s highly regulated healthcare market requires advanced analytical validation, stability testing, impurity profiling, and biologics characterization, and India’s major role in generics, vaccines, biosimilars, and active pharmaceutical ingredient production creates sustained demand for quality control, bioequivalence, and compliance testing. The United Kingdom maintains strong capabilities in life sciences research, biologics, and clinical development, while France supports demand through medicines development, vaccine expertise, public health infrastructure, and regulatory quality systems. Canada supports demand through regulated pharmaceutical manufacturing, clinical research, and public health quality programs, and Italy contributes through established pharmaceutical manufacturing, generics, biologics, and contract testing capabilities. Australia supports demand through clinical research, regulatory-quality laboratories, and biopharmaceutical development, while South Korea is increasingly prominent in biosimilars, biologics manufacturing, and advanced therapy development, requiring specialized analytical services across product characterization, sterility assurance, and release testing. Brazil anchors Latin American demand through its pharmaceutical manufacturing base, regulatory oversight, and clinical research ecosystem, and Mexico is increasingly relevant for pharmaceutical production, nearshoring, and regional quality testing requirements. Russia has domestic pharmaceutical production and public health testing needs, while Spain contributes through established pharmaceutical manufacturing, generics, biologics, and clinical research activity.

Actionable Recommendations for Healthcare Analytical Testing Leaders

Industry leaders should prioritize validated, scalable, and digitally enabled laboratory models that can support complex modalities while maintaining strict regulatory compliance. Key actions include investing in advanced analytical capabilities for biologics, biosimilars, cell and gene therapies, oligonucleotides, mRNA-based products, and combination products; strengthening data integrity frameworks through secure electronic records, audit trails, laboratory information management systems, and controlled data governance; and adopting automation and AI only within validated quality systems. Organizations should expand contamination control expertise, including sterility, endotoxin, bioburden, environmental monitoring, and rapid microbiological methods where appropriate. Building regional testing resilience through qualified laboratory networks can reduce supply chain risk and improve regulatory responsiveness. Leaders should also standardize method lifecycle management, improve cross-functional collaboration between quality, regulatory, manufacturing, and clinical teams, and develop talent in bioanalytics, molecular methods, statistics, computerized system validation, and quality risk management. Continuous readiness for inspections, pharmacopoeial updates, evolving regulatory guidance, and emerging modality-specific expectations should remain a core operating discipline.

Research Methodology for Healthcare Analytical Testing Services

This executive summary is developed using a structured secondary research approach focused on verified and publicly accessible industry evidence. Inputs include regulatory guidance and inspection priorities from recognized health authorities, pharmacopoeial standards, international quality frameworks, peer-reviewed scientific literature, public health agency resources, clinical research and manufacturing trend indicators, and documented advances in analytical technologies. The analysis applies qualitative triangulation across regulatory, scientific, technological, and regional dimensions to identify durable trends without relying on market sizing, share estimates, or forecasts. Emphasis is placed on data integrity, compliance relevance, modality-specific testing requirements, geographic regulatory maturity, laboratory modernization, contamination control, and operational implications for laboratories and healthcare product developers. The methodology excludes promotional claims and prioritizes sources that are transparent, reproducible, and aligned with established healthcare quality standards, including good laboratory practice, good manufacturing practice, pharmacopoeial requirements, and electronic records expectations.

Conclusion: Analytical Testing as a Strategic Pillar of Healthcare Quality

Healthcare analytical testing services are becoming increasingly strategic as the healthcare industry advances toward complex biologics, precision therapies, globally distributed manufacturing, and heightened regulatory expectations. The sector’s evolution is defined by the convergence of scientific specialization, digital laboratory transformation, AI-assisted quality intelligence, and stronger regional testing ecosystems. While traditional quality control remains essential, future competitiveness will depend on validated innovation, robust data governance, contamination control excellence, method lifecycle management, and the ability to support advanced therapies across the full product lifecycle. Organizations that align analytical testing with regulatory science, manufacturing resilience, and patient safety will be best positioned to navigate the next phase of healthcare innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Healthcare Analytical Testing Services Market, by Testing Type
7.1. Introduction
7.2. Qualitative
7.2.1. Spot Tests
7.2.2. Visual Inspection
7.3. Quantitative
7.3.1. Immunoassays
7.3.2. Instrumental Analysis
8. Healthcare Analytical Testing Services Market, by Technology Type
8.1. Introduction
8.2. Chromatography
8.2.1. Gas Chromatography
8.2.2. Liquid Chromatography
8.3. Mass Spectrometry
8.3.1. GC MS
8.3.2. LC MS MS
8.3.3. MALDI TOF
8.4. Microscopy
8.5. PCR
8.6. Spectroscopy
9. Healthcare Analytical Testing Services Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Plasma
9.2.2. Serum
9.2.3. Whole Blood
9.3. Tissue
9.4. Urine
10. Healthcare Analytical Testing Services Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.2.1. Genetic Testing
10.2.2. Infectious Disease
10.2.3. Oncology Markers
10.3. Forensics Testing
10.3.1. DNA Profiling
10.3.2. Toxicology
10.4. Pharmaceutical Testing
10.4.1. Bioanalytical Testing
10.4.2. Quality Control
11. Healthcare Analytical Testing Services Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutes
11.2.1. Research Institutes
11.2.2. Universities
11.3. Contract Research Organizations
11.4. Hospitals & Clinics
11.4.1. Hospital Labs
11.4.2. Pathology Labs
11.5. Pharmaceutical & Biotechnology Companies
12. Healthcare Analytical Testing Services Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Healthcare Analytical Testing Services Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. Healthcare Analytical Testing Services Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. India
14.6. United Kingdom
14.7. France
14.8. Canada
14.9. Italy
14.10. Australia
14.11. South Korea
14.12. Brazil
14.13. Mexico
14.14. Russia
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Almac Group Limited
16.2. ALS Limited
16.3. BioAgilytix Labs, LLC
16.4. Catalent, Inc.
16.5. CD Biosciences Inc.
16.6. Charles River Laboratories International, Inc.
16.7. Element Materials Technology Group Limited
16.8. Eurofins Scientific SE
16.9. Frontage Laboratories, Inc.
16.10. ICON PLC
16.11. Intertek Group PLC
16.12. IQVIA Holdings Inc.
16.13. LabConnect LLC
16.14. Laboratory Corporation of America Holdings
16.15. Medpace, Inc.
16.16. Pace Analytical Services, LLC
16.17. Pharmaron
16.18. Piramal Pharma Solutions
16.19. Quest Diagnostics Incorporated
16.20. Reading Scientific Services Ltd.
16.21. Sartorius AG
16.22. SGS SA
16.23. Syneos Health, Inc.
16.24. Thermo Fisher Scientific Inc.
16.25. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL QUALITATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL QUALITATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL QUALITATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SPOT TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SPOT TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SPOT TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL VISUAL INSPECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL VISUAL INSPECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL VISUAL INSPECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL QUANTITATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL QUANTITATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL QUANTITATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL INSTRUMENTAL ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL INSTRUMENTAL ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL INSTRUMENTAL ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL LIQUID CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL LIQUID CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL LIQUID CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL GC MS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL GC MS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL GC MS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL LC MS MS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL LC MS MS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL LC MS MS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MALDI TOF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MALDI TOF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MALDI TOF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SPECTROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SPECTROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PLASMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PLASMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PLASMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SERUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SERUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SERUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL WHOLE BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL WHOLE BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL WHOLE BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TISSUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL URINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL URINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ONCOLOGY MARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ONCOLOGY MARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ONCOLOGY MARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL FORENSICS TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL FORENSICS TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL FORENSICS TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DNA PROFILING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DNA PROFILING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DNA PROFILING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL TOXICOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL TOXICOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TOXICOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL QUALITY CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL UNIVERSITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL UNIVERSITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL UNIVERSITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITAL LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITAL LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITAL LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL PATHOLOGY LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL PATHOLOGY LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL PATHOLOGY LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 145. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 147. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 148. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 149. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 150. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 151. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 152. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 153. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 154. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 156. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 157. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 158. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 159. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 160. EUROPE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 193. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 194. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 195. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 196. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 197. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 198. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 199. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 200. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 201. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 202. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 204. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 205. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 206. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 207. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 208. AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 225. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 226. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 228. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 229. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 230. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 231. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 232. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 233. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 234. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 235. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 237. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 238. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 239. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 240. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 241. NATO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 242. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 243. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 244. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 245. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 246. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 247. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 248. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 249. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 250. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 251. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 253. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 254. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 255. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 256. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 257. G7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 274. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 275. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 276. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 277. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 278. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 279. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 280. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 281. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 282. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 283. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 285. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 286. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 287. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 288. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 289. BRICS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 290. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 291. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 292. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 293. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 294. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 295. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 296. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 297. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 298. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 299. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 301. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 302. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 303. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 304. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 305. ASEAN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 306. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 307. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 308. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2017-2032 (USD MILLION)
TABLE 309. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2017-2032 (USD MILLION)
TABLE 310. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 311. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 312. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2017-2032 (USD MILLION)
TABLE 313. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 314. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2017-2032 (USD MILLION)
TABLE 315. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 317. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2017-2032 (USD MILLION)
TABLE 318. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2017-2032 (USD MILLION)
TABLE 319. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 320. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 321. GCC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 322. GLOBAL HEALTHCAR

Companies Mentioned

  • Almac Group Limited
  • ALS Limited
  • BioAgilytix Labs, LLC
  • Catalent, Inc.
  • CD Biosciences Inc.
  • Charles River Laboratories International, Inc.
  • Element Materials Technology Group Limited
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • ICON PLC
  • Intertek Group PLC
  • IQVIA Holdings Inc.
  • LabConnect LLC
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • Pace Analytical Services, LLC
  • Pharmaron
  • Piramal Pharma Solutions
  • Quest Diagnostics Incorporated
  • Reading Scientific Services Ltd.
  • Sartorius AG
  • SGS SA
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.46 Billion
Forecasted Market Value ( USD ) by 2032 $ 30.17 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Healthcare Analytical Testing Services - Global Strategic Business Report - Product Image

Healthcare Analytical Testing Services - Global Strategic Business Report

  • Report
  • 203 Pages
  • Global
From
Healthcare Analytical Testing Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Healthcare Analytical Testing Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Healthcare Analytical Testing Services Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Healthcare Analytical Testing Services Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Healthcare Analytical Testing Services Market Report 2026 - Product Image

Healthcare Analytical Testing Services Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Diagnostic Contract Manufacturing Market - Global Forecast 2026-2032 - Product Image

Diagnostic Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From

About the Healthcare Analytical Testing Market

The Healthcare Analytical Testing market within the context of Diagnostics is a rapidly growing sector, with a focus on providing accurate and timely results to healthcare providers. It involves the use of a variety of technologies, such as molecular diagnostics, immunoassays, and flow cytometry, to detect and diagnose diseases. These tests are used to identify the presence of a disease, its severity, and the best course of treatment. The market is driven by the increasing demand for accurate and timely diagnosis, as well as the need for cost-effective solutions. The Healthcare Analytical Testing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.